Our Latest News

[NEWS] – Biofortis obtains ANSM authorization and strengthens its position in the development of microbiota-derived therapies

Biofortis announces that it has obtained authorization from the French National Agency for the Safety of Medicines and Health Products (ANSM) for its activities involving the collection of human stool samples intended for the preparation of fecal microbiota for...
VITAFOODS 2024

VITAFOODS 2024

May 14/15/16th, 2024in Geneva, Swiss[EVENT] - Biofortis will be present at Vitafoods Europe 2024   For this 2024...

Explore

our success stories

Contact

our team

Discover

our capabilities